M1 agonists for the treatment of Alzheimer's disease: Novel properties and clinical update

Annals of the New York Academy of Sciences

Volumn 777, Issue , 1996, Pages 189-196

  Fisher, A ^a   Heldman, E ^a   Gurwitz, D ^a   Haring, R ^a   Karton, Y ^a   Meshulam, H ^a   Pittel, Z ^a   Marciano, D ^a   Brandeis, R ^a   Sadot, E ^b   Barg, Y ^b   Pinkas Kramarski, R ^b   Vogel, Z ^b   Ginzburg, I ^b   Treves, T A ^c   Verchovsky, R ^c   Klimowsky, S ^c   Korczyn, A D ^c  

^a ISRAEL INSTITUTE FOR BIOLOGICAL RESEARCH   (Israel)

^b WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^c TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; AMYLOID PRECURSOR PROTEIN; ARACHIDONIC ACID; CARBACHOL; CEVIMELINE; CYCLIC AMP; MONOCLONAL ANTIBODY; MUSCARINIC AGENT; MUSCARINIC M1 RECEPTOR; NERVE GROWTH FACTOR; PARTIAL AGONIST; PHOSPHATIDYLINOSITIDE; TAU PROTEIN; XANOMELINE;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL TISSUE; BRAIN CORTEX; CHO CELL; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFICACY; DRUG SAFETY; FEMALE; GENETIC TRANSFECTION; HUMAN; HYDROLYSIS; LEARNING DISORDER; MALE; MEMORY; NERVE GROWTH; NEURITE; NONHUMAN; PHOSPHOINOSITIDE METABOLISM; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; RAT; SINGLE BLIND PROCEDURE;

ANIMALIA;

EID: 9344262345     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1996.tb34418.x     Document Type: Review

References (21)

1. FISHER, A. & D. BARAK. Progress and perspectives in new muscarinic agonists. 1994. Drug News & Perspectives 7:453-464.
2. HULME, E. C., N. J. M. BIRDSALL & N. J. BUCKLEY. 1990. Muscarinic receptor subtypes. Annu. Rev. Pharmacol. Toxicol. 30:633-673.
3. COURT, J. A. & E. K. PERRY. 1991. Dementia: The neurochemical basis of putative transmitter orientated therapy. Pharmac. Ther. 52:423-443.
4. HARRISON, P. J., A. J. L. BARTON, B. MCDONALD & R. C. A. PEARSON. 1991. Akheimer's disease: Specific increases in a G-protein subunit (Gsα) mRNA in hippocampal and cortical neurons. Mol. Brain Res. 10:71-81.
5. GURWITZ, D., R. HARING, E. HELDMAN, C. M. FRASER, M. C. MANOR & A. FISHER. 1994. Discrete activation of transduction pathways associated with acetylcholine m1 receptor by several muscarinic ligands. Eur. J. Pharmacol. (Mol. Pharmacol.) 267:21-31.
6. 2+ homeostasis in Alzheimer's disease. TINS 16: 409-414.
7. NITSCH, R. N., B. E. SLACK, R. J. WURTMAN & J. H. GROWDON. 1992. Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors. Science 258:304-307.
8. PINKAS-KRAMARSKI, R., R. STEIN, L. LINDENBOIM & M. SOKOLOVSKY. 1992. Growth factor-like effects mediated by muscarinic receptors in PC12M1 cells. J. Neurochem. 59:2158-2166.
9. FISHER, A., Y. KARTON, E. HELDMAN, D. GURWTTZ, R. HARING, H. MESHULAM, R. BRANDEIS, Z. PITTEL, Y. SEGALL, D. MARCIANO, I. MARKOVITCH, Z. SAMOCHA, E. SHIRIN, M. SAPIR, B. GREEN, G. SHOHAM & D. BARAK. 1993. Progress in medicinal chemistry of novel selective muscarinic agonists. Drug Design and Discovery 9:221-235.
10. BYMASTER, F. P., D. T. WONG, C. H. MITCH, J. S. WARD, D. O. CALLIGARO, D. D. SCHOEPP, H. E. SHANNON, M. J. SHEARDOWN, P. H. OLESEN, P. D. SUZDAK, M. D. B. SWEDBERG & P. SAUERBERG. 1994. Neurochemical Effects of the M1 Muscarinic Agonist Xanomeline (LY246708/NNC11-0232). J. Pharmacol. Exp. Therap. 269:282-289.
11. GURWITZ, D., R. HARING, R. PINKAS-KRAMARSKI, R. STEIN & A. FISHER. 1993. Neurotrophic-like effects of AF102B, an M1-selective muscarinic agonist, in PC12 cells transfected with M1 muscarinic receptors. Soc. Neurosci. Abs. 19:1767.
12. HARING, R., D. GURWITZ, J. BARG, R. PINKAS-KRAMARSKI, E. HELDMAN, Z. PITTEL, H. D. DANENBERG, A. WENGIER, H. MESHULAM, D. MARCIANO, Y. KARTON & A. FISHER. 1995. NGF promotes amyloid precursor protein secretion via muscarinic receptor activation. Biochem. Biophys. Res. Commun. 213: 15-23.
13. HARING, R., D. GURWITZ, J. BARG, R. PINKAS-KRAMARSKI, E. HELDMAN, Z. PITTEL, A. WENGIER, H. MESHULAM, D. MARCIANO, Y. KARTON & A. FISHER. 1994. Amyloid precursor protein secretion via muscarinic receptors: reduced desensitization using the M1-selective agonist AF102B. Biochem. Biophys. Res. Commun. 203:652-658.
14. LEE, V. M.-Y., B. J. BALIN, L. OTVOS & J. Q. TROJANOWSKI. 1991. A68: A major subunit of paired helical filaments and derivatized forms of normal tau. Science 251:675-678.
15. BRANDEIS, R., M. SAPIR, N. HAFIF, S. ABRAHAM, N. OZ, E. STEIN & A. FISHER. 1995. AF150(S): A new functionally selective M1 agonist improved cognitive performance in rats. Pharmacol. Biochem. Behav. 51:667-674.
16. FISHER, A., E. HELDMAN, D. GURWTTZ, R. BRANDEIS, T. A. TREVES, Y. KARTON, R. VERCHOVSKY, S. KLIMOWSKY, H. MESHULAM, Z. PITTEL, D. MARCIANO & A. D. KORCZYN. Selective signaling via novel muscarinic agonists: Implications for Alzheimer's disease treatments, and clinical update. Third Springfield International Symposium on Alzheimer Disease. Springfield, Il, USA, May 11-15, 1994.
17. FARLOW, M., S. I. GRACON, A. HERSHEY, K. W. LEWIS, C. H. SADOWSKY & J. DOLAN-URENO, for the TACRINE STUDY GROUP. 1992. A controlled trial of tacrine in Alzheimer's disease. JAMA 268:2523-2529.
18. CUTLER, N. R., J. J. SRAMEK, R. D. SEIFERT, J. J. CONRAD, T. S. WARDLE, D. J. HURLEY & L. M. THOREN. Safety and tolerance of xanomeline tartrate an M1-specific cholinergic agonist, in patients with Alzheimer's disease. The Third International Symposium on Alzheimer's and Parkinson's Diseases: Recent Developments, Nov. 1-6, 1993, Chicago, IL, USA.
19. BODICK, N. Xanomeline - a potent and selective M1 agonist: Clinical study in mild and moderate Alzheimer's disease. The Sixth International Symposium on Subtypes of Muscarinic Receptors. Fort Lauderdale, FL, USA. Nov. 9-12, 1994.
20. DELONG, A. F., P. L. BONATE, T. GILLESPIE, D. P. HENRY & J. H. SATTERWHITE. Absorption distribution, metabolism and elimination of radiolabeled xanomeline in healthy male subjects. The Third International Symposium on Alzheimer's and Parkinson's Diseases: Recent Developments, Nov. 1-6, 1993, Chicago, IL, USA.
21. CHESSELL, I. P., P. T. FRANCIS, M. N. PANGALOS, R. C. A. PEARSON & D. M. BOWEN. 1993. Localisation of muscarinic (m1) and other neurotransmitter receptors on corticofugal-projecting pyramidal neurones. Brain Res. 632: 86-94.